Results 31 to 40 of about 14,407 (150)

Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?

PLoS ONE, 2023
Background Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology practice has not changed dramatically, with most nephrologists still relying on a kidney biopsy to diagnose membranous nephropathy.
Omar Ragy, Vilma Rautemaa, Alison Smith, Paul Brenchley, Durga Kanigicherla, Patrick Hamilton   +5 more
doaj   +2 more sources

Recurrent Membranous Nephropathy Management after Kidney Transplant: A Case Report

مجله علمی دانشگاه علوم پزشکی کردستان, 2023
Background and Aim: Membranous nephropathy (MN) is a podocytopathy characterized histologically by uniform thickening of the glomerular basement membrane due to the presence of subepithelial immune deposits.
Mohammad saad forghani, Hormat Rahimzadeh, Mahmoud Parvin, anvar mohammadi   +3 more
doaj  

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy

BMC Nephrology, 2020
Background The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous nephropathy.
Maxime Teisseyre, Hélène Perrochia, Pascal Reboul, Sylvain Cariou, Sophie Renaud, Cédric Aglae, Olivier Moranne   +6 more
doaj   +1 more source

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy

Kidney International Reports
Introduction: Rituximab is a first-line treatment for primary membranous nephropathy (pMN), with proven efficacy and safety. The use of monoclonal antibodies such as rituximab can lead to the formation of antidrug antibodies that may interfere with the ...
Marco Allinovi, Maxime Teisseyre, Matteo Accinno, Cecilia Finocchi, Vincent L.M. Esnault, Marion Cremoni, Tommaso Mazzierli, Daniela Lazzarini, Micaela Anna Casiraghi, Céline Fernandez, Kévin Zorzi, Vesna Brglez, Lorenzo Cosmi, Andrea Matucci, Leonardo Caroti, Giulia Antognoli, Calogero Lino Cirami, Alessandra Vultaggio, Barbara Seitz-Polski   +18 more
doaj   +1 more source

Evolution of chronic glomerular disease spectrum and epidemiological characteristics of membranous nephropathy

Linchuang shenzangbing zazhi, 2019
Objective To investigate the composition of chronic glomerular disease spectrum as well as the epidemiological characteristics of membranous nephropathy in Guangdong Provincial People’s Hospital in recent 18 years.
XIE Zhi-yong, LI Zhi-lian, DONG Wei, CHEN Yuan-han, TAO Yi-ming, LI Rui-zhao, WU Yan-hua, LIANG Hua-ban, FU Lei, SHI Wei, LIANG Xin-ling   +10 more
doaj  

Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy

International Journal of Nephrology, 2013
Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy.
Claire Kennedy, Carol Traynor, Patrick O'Kelly, Anthony Dorman, Peter J. Conlon   +4 more
doaj   +1 more source

PLA2R-positive membranous nephropathy in IgG4-related disease

BMC Nephrology
Background IgG4-related disease (IgG4-RD) is a fibroinflammatory disease that affects multiple organs, including the pancreas, lacrimal glands, salivary glands, periaortic/retroperitoneum, and kidney.
Yusuke Ushio, Taro Akihisa, Kazunori Karasawa, Momoko Seki, Shizuka Kobayashi, Yoei Miyabe, Hiroshi Kataoka, Naoko Ito, Sekiko Taneda, Shin’ichi Akiyama, Akira Hebisawa, Mitsuhiro Kawano, Kazuho Honda, Junichi Hoshino   +13 more
doaj   +1 more source

IgG4-related kidney disease (IgG4-RKD) with membranous nephropathy as its initial manifestation: report of one case and literature review

BMC Nephrology, 2019
Background IgG4-related disease (IgG4-RD) often affects multiple organs and tissues, especially the kidneys, and is characterized by interstitial nephritis, obstructive nephropathy, and in rare cases glomerulopathy (including membranous nephropathy ...
Nan-Nan Zhang, Yan-Yun Wang, Ling-Xin Kong, Wan-Zhong Zou, Bao Dong   +4 more
doaj   +1 more source

Neural epidermal growth factor-like 1 expression predicts end-stage renal disease in phospholipase A2 receptor–negative membranous nephropathy: A retrospective cohort stratified by systemic lupus erythematosus

Journal of International Medical Research
Background Neural epidermal growth factor-like 1 protein has emerged as a significant antigen in membranous nephropathy, an important cause of nephrotic syndrome in adults.
Qingqing Rao, Yuan Cheng, Shuling Yue, Haiying Song, Wangyang Li, Dongli Qi, Qijun Wan   +6 more
doaj   +1 more source

PLA2R1 and HLA-DQA1 SNP in patients with primary membranous nephropathy.

PLoS ONE
BackgroundPrimary membranous nephropathy is a widely recognized autoimmune disease associated with podocyte antigens; the most important autoantigen is PLA2R1. PLA2R1 and HLA-DQA1 play important roles in the production of pathogenic antibodies.
Junyi Zhou, Zhijian Zhang, Kezhi Zhou, Leting Zhou, Jing Xue, Bin Liu, Xiran Zhang, Ting Cai, Biao Huang, Yi Zhang, Zhigang Hu, Liang Wang, Xiaobin Liu   +12 more
doaj   +1 more source